| Literature DB >> 21811928 |
Kyoung-Tae Lee1, Tae Woo Jung, Hak-Ju Lee, Seul-Gi Kim, Yu-Su Shin, Wan-Kyunn Whang.
Abstract
Ginsenosides, which are active compounds found in ginseng (Panax ginseng), are used as antidiabetic treatments. The aim of this study was to determine whether Rb2, a type of ginsenoside, regulates hepatic gluconeogenesis through AMP-activated protein kinase (AMPK) and the orphan nuclear receptor small heterodimer partner (SHP) in hyperlipidemic conditions used as an in vitro model of type 2 diabetes. Considering these results, we concluded that Rb2 may inhibit palmitate-induced gluconeogenesis via AMPK-induced SHP by relieving ER stress, a cause of gluconeogenesis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21811928 DOI: 10.1007/s12272-011-0719-6
Source DB: PubMed Journal: Arch Pharm Res ISSN: 0253-6269 Impact factor: 4.946